Full video transcriptClick to expand
Auto-generated transcript of @mrslread's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:01hanging tik tokas so it's Friday night which means it's injection night for the
- 0:07mosem pick
- 0:09um on this is the one milligram pen i'm going to be taking half of that which is 0.5 milligrams
- 0:18um this is the pen now to take half of the one milligram pen you need 38 clicks
- 0:27let's get this ready one sec right so what i have just noticed on the pen is this is where you turn
- 0:38it and it's got little lines so you can count the clicks um now i've just counted to 30k and there
- 0:47is actually it goes dash and then dot and then dash again so it does actually there is a little
- 0:53marker for you um if you are just doing the 0.5 so take the lid off these are the little
- 1:03needles that come with it so i'm just gonna obviously make sure you wash your hands
- 1:24i'm gonna roll the first cap off and then we've got the needle cap so i'm just going to do it in my
- 1:35arm this week it's a new one not tried the arm yet so hopefully the side effects won't be too bad
- 1:42that's the needle there so it would drop going out of there
- 1:52just going to do it on back and click the button and then after it's finished
- 2:03count for a few seconds that even's count six or ten that's it all done so i'm just going to put
- 2:26the cap back on the needle cap back on run out time here um twist that off that cap comes off
- 2:38careful those needle the other end as well so hold it this way this way then put that bit in your
- 2:42sharps bend put the cap back on and that's it for another week so fingers crossed we'll see what
- 2:51this week will bring
Ozempic injection videos: what TikTok shows vs. clinical reality
Quick answer
The creator is self-administering subcutaneous semaglutide (Ozempic) at what she describes as 0.5mg, using a click-counting method on a 1mg pen rather than a dose-specific pen. Her injection technique, including hand hygiene, needle handling, post-injection hold time, and sharps disposal, is broadly consistent with standard guidance, but the click-counting dosing method is not manufacturer-validated and introduces potential for inaccurate dose delivery.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Semaglutide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Ozempic injection videos: what TikTok shows vs. clinical reality, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this semaglutide video claims cluster
Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Ozempic injection videos: what TikTok shows vs. clinical reality" from Laura Read. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is self-administering subcutaneous semaglutide (Ozempic) at what she describes as 0.
The reason this review is not generic is the source wording and the canonical claim label "glp1 ozempic myozempicjourney injection fridaynight." In this clip, the useful excerpt is: "hanging tik tokas so it's Friday night which means it's injection night for the mosem pick um on this is the one milligram pen i'm going to be taking half of that which is 0." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator is self-administering subcutaneous semaglutide (Ozempic) at what she describes as 0.
FormBlends verdict
Compounded Semaglutide safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is self-administering subcutaneous semaglutide (Ozempic) at what she describes as 0.5mg, using a click-counting method on a 1mg pen rather than a dose-specific pen. Her injection technique, including hand hygiene, needle handling, post-injection hold time, and sharps disposal, is broadly consistent with standard guidance, but the click-counting dosing method is not manufacturer-validated and introduces potential for inaccurate dose delivery.
- Novo Nordisk does not endorse click-counting as a dosing method on the 1mg Ozempic pen. The 0.5mg starting dose has its own dedicated pen.
- Injection technique basics shown in the video (hand hygiene, dual cap removal, post-injection hold, sharps disposal) are consistent with NHS and manufacturer guidance.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.
Review Compounded SemaglutideWhat You'll Learn
- Novo Nordisk does not endorse click-counting as a dosing method on the 1mg Ozempic pen. The 0.5mg starting dose has its own dedicated pen.
- Injection technique basics shown in the video (hand hygiene, dual cap removal, post-injection hold, sharps disposal) are consistent with NHS and manufacturer guidance.
- Wilding et al. (2021, NEJM) confirmed GI side effects for semaglutide are dose-dependent, not injection-site-dependent. Switching to the arm is unlikely to reduce nausea.
- The upper arm is a manufacturer-approved subcutaneous injection site for Ozempic alongside the abdomen and thigh.
- An estimated 149,600 viewers may be replicating this click-counting method without knowing it lacks pharmaceutical validation.
- If you are prescribed 0.5mg semaglutide, confirm with your pharmacist or prescriber which specific pen you should be using before attempting manual dose adjustments.
- Sharps disposal in a designated sharps bin, as demonstrated, is the correct and legally required method in the UK. Disposing of needles in household waste is not permitted.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @mrslread actually say?
In this 149K-view video, @mrslread walks through a Friday-night Ozempic injection using a 1mg pen, claiming that "38 clicks" equals a 0.5mg dose. She demonstrates needle attachment, injection site selection (choosing the arm for the first time), and proper sharps disposal. She also mentions counting six to ten seconds after pressing the button before withdrawing the pen.
This is a practical how-to video, not a medical claims video. She is not selling anything or diagnosing anyone. But given the view count, the mechanical accuracy of what she describes matters. A lot of people are watching this and will try to replicate it.
Does the science back this up?
The 38-click method for hitting 0.5mg on the Ozempic 1mg pen is a real, documented practice, but it comes with a significant asterisk. Novo Nordisk designed the pen to deliver fixed doses, not click-counted ones.
The Ozempic 1mg pen (the blue pen) is pre-set to deliver 1mg per injection. The 0.5mg dose is dispensed by a different pen, the red one, which is specifically calibrated for that dose. Using click-counting to halve a 1mg pen dose is an off-label workaround that circulates widely in patient communities online.
There is no published peer-reviewed data validating the accuracy of click-counting as a dosing method for this specific pen. Novo Nordisk does not endorse or document this technique in prescribing information. The concern is real: inconsistent dose delivery could mean under-dosing or over-dosing, neither of which is trivial for a drug with a narrow therapeutic window and documented dose-dependent side effects (Davies et al., 2021, Diabetes Care).
What did they get wrong (or right)?
She gets several things right. Washing hands before injection, removing both needle caps in the correct order, holding for several seconds post-injection, and using a sharps bin are all consistent with NHS and manufacturer guidance. These are not small details. Needle-stick injuries from improper disposal are a documented public health issue.
The arm injection site is also legitimate. Subcutaneous injection into the back of the upper arm is an approved site alongside the abdomen and thigh (Novo Nordisk prescribing information, 2023). Her note that she is trying the arm "for the first time" and hoping side effects "won't be too bad" is anecdotal, and there is no clinical evidence that injection site changes meaningfully alter GI side effect profiles for semaglutide.
The click-counting method is the main problem here. Saying "38 clicks" equals 0.5mg is presented as fact to nearly 150,000 viewers, but this is not manufacturer-verified dosing guidance. It is borrowed from online patient forums. That distinction matters.
What should you actually know?
If your prescriber has directed you to take 0.5mg of semaglutide, you should be using the pen that is calibrated for that dose, not manually dialing a click count on a higher-dose pen. That is a conversation to have with your prescriber or pharmacist, not something to troubleshoot from TikTok.
The injection technique shown is largely reasonable as a visual reference, but technique videos on social media cannot replace in-person training or the patient information leaflet included with your prescription. If you are new to injectable medications, your pharmacist or prescribing clinician should walk you through administration before you attempt it alone.
On the side effect comment: GI symptoms like nausea and vomiting are the most common adverse effects of semaglutide and are dose-dependent (Wilding et al., 2021, NEJM). Changing injection sites does not appear to modulate this. If side effects are severe or persistent, that is a clinical conversation, not an injection technique problem.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Laura Read · TikTok creator
149.6K views on this video
#Ozempic #myozempicjourney #injection #fridaynight
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about novo nordisk does not endorse click-counting as a dosing method?
Novo Nordisk does not endorse click-counting as a dosing method on the 1mg Ozempic pen. The 0.5mg starting dose has its own dedicated pen.
What does the video say about injection technique basics shown in the video (hand hygiene, dual?
Injection technique basics shown in the video (hand hygiene, dual cap removal, post-injection hold, sharps disposal) are consistent with NHS and manufacturer guidance.
What does the video say about wilding et al. (2021, nejm) confirmed gi side effects for?
Wilding et al. (2021, NEJM) confirmed GI side effects for semaglutide are dose-dependent, not injection-site-dependent. Switching to the arm is unlikely to reduce nausea.
What does the video say about the upper arm?
The upper arm is a manufacturer-approved subcutaneous injection site for Ozempic alongside the abdomen and thigh.
What does the video say about an estimated 149,600 viewers may be replicating this click-counting method?
An estimated 149,600 viewers may be replicating this click-counting method without knowing it lacks pharmaceutical validation.
What does the video say about if you?
If you are prescribed 0.5mg semaglutide, confirm with your pharmacist or prescriber which specific pen you should be using before attempting manual dose adjustments.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Laura Read, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.